
Amplía el crédito en dólares al 15% para empresas
El Banco Central permite que las financieras usen hasta el 15 % de sus depósitos en dólares para otorgar préstamos a empresas, una medida que busca reactivar la inversión productiva.

AI stocks are popular, but choosing the right one is difficult. Chip manufacturers led the year, but in the last month, money moved towards companies that may not be the best options for the next three years.
AI stocks are on the rise, but choosing the right one is a challenge. Investors must carefully consider their investment strategy to avoid costly mistakes.
Investors are drawn to AI stocks due to their growth potential, but the competition is fierce and the market is volatile. Traders must stay alert to market changes and adjust their strategy as needed.
The company that leads the market at a given time may not be the same in the future. Traders must consider factors such as innovation, management, and financial health before making an investment decision.
Research and strategy are key to choosing the right AI stocks. Shareholders must analyze the company's history, market position, and growth potential before investing.
In the next 30 days, investors must stay alert to market changes and adjust their strategy as needed. Investing in AI stocks requires patience, discipline, and a deep understanding of the market.
The future of AI stocks is uncertain, but one thing is clear: the competition will be fierce. Companies that innovate and adapt quickly to change will be the ones leading the market in the future.
In summary, AI stocks can be a good option for investors willing to take risks and adjust their strategy as needed. However, it is essential to conduct thorough research and develop a solid strategy before investing.

El Banco Central permite que las financieras usen hasta el 15 % de sus depósitos en dólares para otorgar préstamos a empresas, una medida que busca reactivar la inversión productiva.

La acción de Moderna subió 95 % después de que su vacuna de ARN mensajero contra el cáncer, desarrollada con Merck, obtuviera el primer resultado positivo en una fase 3.

El pronóstico más audaz de Wall Street sitúa al S&P 500 en 9.000 para fin de 2027, un 17 % por encima del nivel actual.